Showing results (1-10 of 43) with videos related to
Sort By:
Pageof 5
Rheumatology and Immunology Research|February 15, 2023
JAK/STAT Pathway Targeting in Primary Sjögren SyndromeSaviana Gandolfo, Francesco CicciaClinical Immunology (Orlando, Fla.)|August 16, 2022
Will fecal microbiota transplantation eventually be an effective therapeutic strategy for systemic lupus erythematosus?Francesco Ciccia, Saviana GandolfoExpert Opinion on Emerging Drugs|July 10, 2019
Emerging drugs for primary Sjögren's syndromeSaviana Gandolfo, Salvatore De VitaClinical and Experimental Rheumatology|August 30, 2019
Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjögren's syndromeSaviana Gandolfo, Salvatore De VitaExpert Review of Clinical Immunology|July 27, 2019
Predicting lymphoma development in patients with Sjögren's syndromeSalvatore De Vita, Saviana GandolfoThe Lancet. Rheumatology|November 23, 2024
Understanding the spectrum from preclinical psoriatic arthritis to early diagnosis of the diseaseFrancesco Ciccia, Saviana Gandolfo, Roberto Caporali, et al.The Lancet. Rheumatology|May 9, 2024
Precision medicine in Sjögren's diseaseSaviana Gandolfo, Michele Bombardieri, Jacques-Olivier Pers, et al.Rheumatology and Immunology Research|April 4, 2024
The effect of anti-TNF drugs on the intestinal microbiota in patients with spondyloarthritis, rheumatoid arthritis, and inflammatory bowel diseasesFrancesco Ciccia, Nikolas Konstantine Dussias, Saviana Gandolfo, et al.The Lancet. Rheumatology|January 22, 2024
Autoantibody-negative rheumatoid arthritis: still a challenge for the rheumatologistSerena Bugatti, Ludovico De Stefano, Saviana Gandolfo, et al.Clinical and Experimental Rheumatology|August 30, 2018
The evaluation of disease activity in Sjögren's syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort studySalvatore De Vita, Saviana Gandolfo, Sara Zandonella Callegher, et al.Pageof 5